Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Clotting; factor VIII related antigen

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 85244 refers to a laboratory test that measures the level of factor VIII related antigen in the blood. Factor VIII is a crucial protein that plays a significant role in the blood clotting process. A deficiency in this protein is often linked to Hemophilia A, a genetic disorder that primarily affects males due to its X-linked inheritance pattern. Hemophilia A can manifest in varying degrees of severity based on the percentage of factor VIII present in the blood. The severe form, characterized by less than 1% of normal factor VIII levels, occurs in approximately 60% of cases, while the moderate form (1-5% factor VIII) is seen in about 15% of cases, and the mild form (6-30% factor VIII) in roughly 25% of patients. Individuals with mild hemophilia typically experience bleeding only in response to significant injuries, whereas those with moderate hemophilia may have spontaneous bleeding episodes, particularly in joints and soft tissues. In contrast, individuals with severe factor VIII deficiency are at risk for spontaneous bleeding under various circumstances. The factor VIII related antigen test is instrumental in evaluating the effectiveness of factor VIII replacement therapy, determining carrier status in potential hemophilia cases, and identifying patients who may exhibit cross-reactive positivity (CRP). The test is performed on a blood sample obtained through venipuncture, which is a separately reportable procedure, and the analysis is conducted using immunoassay techniques.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The factor VIII related antigen test (CPT® Code 85244) is indicated for several specific clinical scenarios, particularly in the context of bleeding disorders. The following conditions may warrant the performance of this test:

  • Assessment of Hemophilia A This test is crucial for diagnosing and managing Hemophilia A, a genetic disorder characterized by a deficiency in factor VIII, leading to impaired blood clotting.
  • Evaluation of Factor VIII Replacement Therapy The test is used to monitor the effectiveness of factor VIII replacement therapy in patients with hemophilia, ensuring that adequate levels of the protein are maintained to prevent bleeding episodes.
  • Determination of Carrier Status The test can help identify individuals who are carriers of the hemophilia gene, particularly in families with a history of the disorder, aiding in genetic counseling and family planning.
  • Identification of Cross-Reactive Positivity (CRP) The test may be utilized to distinguish patients who may exhibit cross-reactive positivity, which can impact treatment decisions and management strategies.

2. Procedure

The procedure for conducting the factor VIII related antigen test involves several key steps that ensure accurate measurement of the antigen levels in the blood. The following outlines the procedural steps:

  • Step 1: Patient Preparation Prior to the test, the patient may be instructed to avoid certain medications or supplements that could interfere with the results. It is essential to gather a thorough medical history to understand any potential factors that may affect the test outcome.
  • Step 2: Venipuncture A qualified healthcare professional performs venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to draw a sufficient volume of blood for testing. The venipuncture procedure is separately reportable and must be documented appropriately.
  • Step 3: Sample Handling Once the blood sample is collected, it must be handled and processed according to laboratory protocols. This includes labeling the sample accurately and ensuring it is transported to the laboratory under the correct conditions to maintain sample integrity.
  • Step 4: Immunoassay Testing The laboratory performs the analysis using immunoassay techniques, which are designed to quantify the level of factor VIII related antigen present in the blood sample. This method provides reliable and precise results that are essential for clinical decision-making.
  • Step 5: Result Interpretation After the testing is complete, the results are interpreted by a qualified healthcare professional. The findings will inform the management of the patient’s condition, including any necessary adjustments to treatment plans.

3. Post-Procedure

After the factor VIII related antigen test is completed, patients may be advised on post-procedure care, although specific instructions may vary based on individual circumstances. Generally, patients can resume normal activities immediately following the venipuncture, but they should be monitored for any signs of excessive bleeding or bruising at the puncture site. If any adverse reactions occur, such as prolonged bleeding or discomfort, patients should contact their healthcare provider for further evaluation. Additionally, the results of the test will typically be discussed with the patient during a follow-up appointment, where the implications for treatment and management of their condition will be addressed.

Short Descr CLOT FACTOR VIII RELTD ANTGN
Medium Descr CLOTTING FACTOR VIII RELATED ANTIGEN
Long Descr Clotting; factor VIII related antigen
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
Date
Action
Notes
2013-01-01 Changed Short Descriptor changed.
Pre-1990 Added Code added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"